Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Apr 15 04:00PM ET
147.59
Dollar change
+0.07
Percentage change
0.05
%
IndexDJIA, S&P 500 P/E26.46 EPS (ttm)5.58 Insider Own0.16% Shs Outstand2.41B Perf Week-2.64%
Market Cap355.51B Forward P/E13.39 EPS next Y11.02 Insider Trans-1.74% Shs Float2.40B Perf Month-7.30%
Income14.17B PEG5.51 EPS next Q2.64 Inst Own71.47% Short Float0.66% Perf Quarter-9.11%
Sales93.02B P/S3.82 EPS this Y7.46% Inst Trans-0.39% Short Ratio2.22 Perf Half Y-5.59%
Book/sh28.57 P/B5.17 EPS next Y3.36% ROA7.62% Short Interest15.94M Perf Year-11.15%
Cash/sh9.52 P/C15.51 EPS next 5Y4.80% ROE18.57% 52W Range144.95 - 175.97 Perf YTD-5.84%
Dividend Est.4.81 (3.26%) P/FCF19.48 EPS past 5Y-0.27% ROI14.80% 52W High-16.13% Beta0.54
Dividend TTM4.76 (3.23%) Quick Ratio0.91 Sales past 5Y1.31% Gross Margin67.94% 52W Low1.82% ATR (14)2.03
Dividend Ex-DateFeb 16, 2024 Current Ratio1.16 EPS Y/Y TTM-17.52% Oper. Margin25.66% RSI (14)24.03 Volatility1.37% 1.22%
Employees131900 Debt/Eq0.44 Sales Y/Y TTM-2.10% Profit Margin15.23% Recom2.30 Target Price176.33
Option/ShortYes / Yes LT Debt/Eq0.39 EPS Q/Q25.42% Payout84.93% Rel Volume1.18 Prev Close147.52
Sales Surprise1.78% EPS Surprise0.39% Sales Q/Q-9.83% EarningsApr 16 BMO Avg Volume7.19M Price147.59
SMA20-4.47% SMA50-6.14% SMA200-7.13% Trades Volume8,490,880 Change0.05%
Date Action Analyst Rating Change Price Target Change
Dec-13-23Downgrade Wells Fargo Overweight → Equal Weight $170 → $163
Dec-01-23Upgrade UBS Neutral → Buy $167 → $180
Oct-05-23Initiated RBC Capital Mkts Outperform $178
Sep-06-23Initiated HSBC Securities Hold $175
May-30-23Resumed Citigroup Buy $185
Mar-29-23Initiated UBS Neutral $164
Mar-01-23Initiated Guggenheim Neutral $161
Nov-18-22Initiated Credit Suisse Neutral $170
Oct-18-22Initiated Barclays Equal Weight $175
Oct-14-22Reiterated BofA Securities Neutral $185 → $178
Today 03:06AM
02:12AM
Apr-15-24 04:46PM
02:51PM
10:40AM
10:06AM Loading…
10:06AM
09:55AM
08:00AM
07:43AM
06:50AM
03:34AM
Apr-14-24 09:30AM
Apr-13-24 07:23PM
02:47PM
Apr-12-24 05:45PM
04:44PM Loading…
04:44PM
09:09AM
08:00AM
06:12AM
Apr-11-24 02:05PM
10:10AM
09:15AM
09:00AM
Apr-10-24 01:01PM
12:47PM
11:43AM
04:57AM
Apr-09-24 04:08PM
10:00AM
09:51AM
07:37AM Loading…
07:37AM
04:21AM
Apr-08-24 06:06PM
05:50PM
11:52AM
09:40AM
09:23AM
09:18AM
05:19AM
03:46AM
Apr-07-24 02:30PM
Apr-06-24 08:15AM
Apr-05-24 11:54PM
11:36PM
04:13PM
04:13PM
03:27PM
01:10PM
12:12PM
11:52AM
11:45AM
11:07AM
10:49AM
10:40AM
09:59AM
09:31AM
08:56AM
08:45AM
07:24AM
06:41AM
06:39AM
06:36AM
06:31AM
Apr-04-24 06:01PM
05:59PM
05:55PM
07:30AM
04:05AM
Apr-03-24 12:10PM
11:12AM
08:48AM
05:39AM
Apr-02-24 05:45PM
04:30PM
Apr-01-24 02:01PM
11:52AM
08:00AM
Mar-31-24 11:52AM
03:10AM
Mar-30-24 05:19AM
Mar-29-24 12:16PM
09:00AM
09:00AM
07:39AM
05:00AM
Mar-28-24 02:36PM
06:15AM
Mar-27-24 03:56PM
03:39PM
03:32PM
06:41AM
Mar-26-24 05:45PM
05:24PM
04:24PM
04:15PM
02:33PM
02:30PM
02:23PM
08:02AM
06:18AM
Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in the interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Broadhurst VanessaEVP, Global Corp AffairsMar 13 '24Sale162.168,8911,441,76515,043Mar 13 04:36 PM
JOHNSON & JOHNSON10% OwnerFeb 29 '24Option Exercise0.723,8552,7924,103,430Mar 06 03:42 PM
JOHNSON & JOHNSON10% OwnerFeb 16 '24Sale25.813,72596,1424,099,575Mar 06 03:42 PM
Decker Robert JVP Corporate ControllerFeb 13 '24Option Exercise0.00313019,059Feb 15 04:53 PM
Broadhurst VanessaEVP, Global Corp AffairsFeb 13 '24Option Exercise0.00408024,143Feb 15 04:53 PM
Forminard ElizabethExecutive VP, General CounselFeb 13 '24Option Exercise0.0065108,576Feb 15 04:53 PM
Duato JoaquinCEO and Chairman of the BoardFeb 13 '24Option Exercise0.003,4700364,809Feb 15 04:53 PM
Hait WilliamSee RemarksFeb 13 '24Option Exercise0.00834039,074Feb 15 04:53 PM
Fasolo PeterExec VP, Chief HR OfficerFeb 13 '24Option Exercise0.009250112,550Feb 15 04:53 PM
Schmid TimothyEVP, WW Chair, MedTechFeb 13 '24Option Exercise0.00499013,290Feb 15 04:53 PM
Swanson James D.EVP, CIOFeb 13 '24Option Exercise0.00447014,765Feb 15 04:53 PM
Taubert Jennifer LEVP, WWC. Innovative MedicineFeb 13 '24Option Exercise0.001,3020155,517Feb 15 04:53 PM
Wolk Joseph JExec VP, CFOFeb 13 '24Option Exercise0.001,780069,663Feb 15 04:53 PM
Wengel Kathryn EEVP, Chief TO and Risk OfficerFeb 13 '24Option Exercise0.00651082,599Feb 15 04:53 PM
Decker Robert JVP Corporate ControllerFeb 12 '24Option Exercise0.001,912019,269Feb 14 06:36 PM
Duato JoaquinCEO and Chairman of the BoardFeb 12 '24Option Exercise0.0036,6180377,239Feb 14 06:36 PM
Taubert Jennifer LEVP, WWC. Innovative MedicineFeb 12 '24Option Exercise0.0026,2020167,618Feb 14 06:36 PM
Forminard ElizabethExecutive VP, General CounselFeb 12 '24Option Exercise0.002,85908,959Feb 14 06:36 PM
Wolk Joseph JExec VP, CFOFeb 12 '24Option Exercise0.0025,835078,699Feb 14 06:36 PM
Hait WilliamSee RemarksFeb 12 '24Option Exercise0.008,932042,316Feb 14 06:36 PM
Broadhurst VanessaEVP, Global Corp AffairsFeb 12 '24Option Exercise0.004,701025,081Feb 14 06:36 PM
Wengel Kathryn EEVP, Chief TO and Risk OfficerFeb 12 '24Option Exercise0.0013,813089,014Feb 14 06:36 PM
Schmid TimothyEVP, WW Chair, MedTechFeb 12 '24Option Exercise0.005,736015,678Feb 14 06:36 PM
Swanson James D.EVP, CIOFeb 12 '24Option Exercise0.005,456016,013Feb 14 06:36 PM
Fasolo PeterExec VP, Chief HR OfficerFeb 12 '24Option Exercise0.0014,9600118,644Feb 14 06:36 PM
Duato JoaquinCEO and Chairman of the BoardFeb 09 '24Option Exercise90.44130,96911,844,836439,283Feb 13 05:18 PM
Taubert Jennifer LEVP, WW Chair, PharmaceuticalsFeb 09 '24Option Exercise90.4459,3975,371,865200,813Feb 12 07:25 PM
Taubert Jennifer LEVP, WW Chair, PharmaceuticalsFeb 09 '24Sale156.2759,3979,281,969141,416Feb 12 07:25 PM
Taubert Jennifer LEVP, WW Chair, PharmaceuticalsFeb 08 '24Option Exercise0.003,7390143,329Feb 12 07:25 PM
Decker Robert JVP Corporate ControllerFeb 08 '24Option Exercise0.00655017,572Feb 12 07:24 PM
Broadhurst VanessaEVP, Global Corp AffairsFeb 08 '24Option Exercise0.001,880021,083Feb 12 07:24 PM
Hait WilliamSee RemarksFeb 08 '24Option Exercise0.003,059034,497Feb 12 07:24 PM
Fasolo PeterExec VP, Chief HR OfficerFeb 08 '24Option Exercise0.002,1350104,465Feb 12 07:24 PM
Schmid TimothyEVP, WW Chair, MedTechFeb 08 '24Option Exercise0.001,964010,943Feb 12 07:24 PM
Swanson James D.See RemarksFeb 08 '24Option Exercise0.001,868011,111Feb 12 07:24 PM
Forminard ElizabethExecutive VP, General CounselFeb 08 '24Option Exercise0.0097906,463Feb 12 07:24 PM
Wolk Joseph JExec VP, CFOFeb 08 '24Option Exercise0.003,686053,911Feb 12 07:25 PM
Wengel Kathryn EEVP, Chief TO and Risk OfficerFeb 08 '24Option Exercise0.001,971067,905Feb 12 07:25 PM
Duato JoaquinCEO and Chairman of the BoardFeb 08 '24Option Exercise0.005,2250310,583Feb 12 07:25 PM
Hait WilliamSee RemarksJul 26 '23Option Exercise90.4414,6981,329,287102,445Jul 27 05:52 PM
Hait WilliamSee RemarksJul 26 '23Sale172.0014,6982,528,05687,747Jul 27 05:52 PM
Fasolo PeterExec VP, Chief HR OfficerJul 25 '23Sale170.3220,0003,406,498102,696Jul 27 05:52 PM
Wengel Kathryn EEVP, Chief TO and Risk OfficerJun 12 '23Sale160.0012,4651,994,40065,934Jun 14 04:19 PM